| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | PLEKHG1 ARHGAP22 ARHGEF28 ARHGAP31 IQSEC1 TBC1D22B ARHGEF2 SIPA1L2 ARHGAP21 | 1.91e-05 | 507 | 60 | 9 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | PLEKHG1 ARHGAP22 ARHGEF28 ARHGAP31 IQSEC1 TBC1D22B ARHGEF2 SIPA1L2 ARHGAP21 | 1.91e-05 | 507 | 60 | 9 | GO:0030695 |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 3.81e-05 | 22 | 60 | 3 | GO:0051010 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 5.75e-04 | 12 | 60 | 2 | GO:0002162 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 5.75e-04 | 12 | 60 | 2 | GO:0004706 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | PLEKHG1 ARHGAP22 ARHGEF28 ARHGAP31 IQSEC1 APC TBC1D22B ARHGEF2 SIPA1L2 ARHGAP21 SLX4 RECK | 9.04e-04 | 1418 | 60 | 12 | GO:0030234 |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.50e-03 | 279 | 60 | 5 | GO:0005096 | |
| GeneOntologyMolecularFunction | tubulin binding | 1.76e-03 | 428 | 60 | 6 | GO:0015631 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 4.74e-06 | 38 | 61 | 4 | GO:0007026 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | PLEKHG1 ARHGAP22 ARHGEF28 ARHGAP31 IQSEC1 ARHGEF2 SIPA1L2 ARHGAP21 | 5.94e-06 | 333 | 61 | 8 | GO:0051056 |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 7.12e-06 | 42 | 61 | 4 | GO:0031114 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 1.56e-05 | 51 | 61 | 4 | GO:0031111 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 4.35e-05 | 66 | 61 | 4 | GO:0007019 | |
| GeneOntologyBiologicalProcess | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 8.55e-05 | 5 | 61 | 2 | GO:1904261 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane assembly involved in embryonic body morphogenesis | 8.55e-05 | 5 | 61 | 2 | GO:1904259 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing, spreading of epidermal cells | 8.55e-05 | 5 | 61 | 2 | GO:1903690 | |
| GeneOntologyBiologicalProcess | basement membrane assembly involved in embryonic body morphogenesis | 8.55e-05 | 5 | 61 | 2 | GO:2001197 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.40e-04 | 89 | 61 | 4 | GO:1901880 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | PLEKHG1 ARHGAP22 ARHGEF28 ARHGAP31 IQSEC1 ARHGEF2 SIPA1L2 ARHGAP21 | 1.78e-04 | 538 | 61 | 8 | GO:0007264 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 2.20e-04 | 100 | 61 | 4 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 2.65e-04 | 105 | 61 | 4 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 2.95e-04 | 108 | 61 | 4 | GO:0031110 | |
| GeneOntologyBiologicalProcess | establishment of mitotic spindle localization | 2.99e-04 | 44 | 61 | 3 | GO:0040001 | |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix disassembly | 3.81e-04 | 10 | 61 | 2 | GO:0090091 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 4.65e-04 | 11 | 61 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | regulation of wound healing, spreading of epidermal cells | 4.65e-04 | 11 | 61 | 2 | GO:1903689 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 5.57e-04 | 12 | 61 | 2 | GO:0070831 | |
| GeneOntologyCellularComponent | anchoring junction | USP53 ARHGAP22 ANK2 CLASP1 ARHGAP31 PKP3 TRPC4 APC CLASP2 ARHGEF2 ARHGAP21 TJP3 | 1.76e-05 | 976 | 60 | 12 | GO:0070161 |
| GeneOntologyCellularComponent | cortical microtubule cytoskeleton | 8.06e-05 | 5 | 60 | 2 | GO:0030981 | |
| GeneOntologyCellularComponent | basal cortex | 1.69e-04 | 7 | 60 | 2 | GO:0045180 | |
| GeneOntologyCellularComponent | glutamatergic synapse | ARHGAP22 NSMF TENM3 IQSEC1 APC CLASP2 ARHGEF2 SIPA1L2 BEGAIN | 5.03e-04 | 817 | 60 | 9 | GO:0098978 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 5.17e-04 | 129 | 60 | 4 | GO:0030863 | |
| GeneOntologyCellularComponent | bicellular tight junction | 5.47e-04 | 131 | 60 | 4 | GO:0005923 | |
| GeneOntologyCellularComponent | cell cortex | 6.70e-04 | 371 | 60 | 6 | GO:0005938 | |
| GeneOntologyCellularComponent | tight junction | 6.84e-04 | 139 | 60 | 4 | GO:0070160 | |
| GeneOntologyCellularComponent | Wnt signalosome | 9.47e-04 | 16 | 60 | 2 | GO:1990909 | |
| GeneOntologyCellularComponent | apical junction complex | 1.10e-03 | 158 | 60 | 4 | GO:0043296 | |
| GeneOntologyCellularComponent | cell-cell junction | 1.47e-03 | 591 | 60 | 7 | GO:0005911 | |
| GeneOntologyCellularComponent | kinetochore microtubule | 1.80e-03 | 22 | 60 | 2 | GO:0005828 | |
| GeneOntologyCellularComponent | kinetochore | 1.82e-03 | 181 | 60 | 4 | GO:0000776 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 2.29e-03 | 193 | 60 | 4 | GO:0000779 | |
| GeneOntologyCellularComponent | mitotic spindle | 2.66e-03 | 201 | 60 | 4 | GO:0072686 | |
| GeneOntologyCellularComponent | ruffle | 2.90e-03 | 206 | 60 | 4 | GO:0001726 | |
| GeneOntologyCellularComponent | microtubule plus-end | 2.92e-03 | 28 | 60 | 2 | GO:0035371 | |
| GeneOntologyCellularComponent | ruffle membrane | 3.71e-03 | 108 | 60 | 3 | GO:0032587 | |
| GeneOntologyCellularComponent | microtubule | 4.17e-03 | 533 | 60 | 6 | GO:0005874 | |
| GeneOntologyCellularComponent | microtubule end | 5.33e-03 | 38 | 60 | 2 | GO:1990752 | |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 6.61e-03 | 133 | 60 | 3 | GO:0005881 | |
| GeneOntologyCellularComponent | chromosomal region | 7.13e-03 | 421 | 60 | 5 | GO:0098687 | |
| GeneOntologyCellularComponent | axonal growth cone | 7.41e-03 | 45 | 60 | 2 | GO:0044295 | |
| GeneOntologyCellularComponent | cell cortex region | 7.41e-03 | 45 | 60 | 2 | GO:0099738 | |
| GeneOntologyCellularComponent | focal adhesion | 7.85e-03 | 431 | 60 | 5 | GO:0005925 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 8.13e-03 | 276 | 60 | 4 | GO:0000775 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 8.74e-03 | 49 | 60 | 2 | GO:0099092 | |
| GeneOntologyCellularComponent | cell-substrate junction | 8.78e-03 | 443 | 60 | 5 | GO:0030055 | |
| Domain | MLK1/MLK2/MLK4 | 5.47e-05 | 4 | 57 | 2 | IPR016231 | |
| Domain | CLASP_N | 5.47e-05 | 4 | 57 | 2 | PF12348 | |
| Domain | CLASP_N_dom | 5.47e-05 | 4 | 57 | 2 | IPR024395 | |
| Domain | MAP3K10 | 5.47e-05 | 4 | 57 | 2 | IPR015785 | |
| Domain | PDZ | 6.98e-05 | 141 | 57 | 5 | PF00595 | |
| Domain | PDZ | 8.77e-05 | 148 | 57 | 5 | SM00228 | |
| Domain | - | 9.35e-05 | 150 | 57 | 5 | 2.30.42.10 | |
| Domain | PDZ | 9.65e-05 | 151 | 57 | 5 | PS50106 | |
| Domain | PDZ | 9.95e-05 | 152 | 57 | 5 | IPR001478 | |
| Domain | SH3_2 | 1.37e-04 | 86 | 57 | 4 | IPR011511 | |
| Domain | SH3_2 | 1.37e-04 | 86 | 57 | 4 | PF07653 | |
| Domain | PH | 1.98e-04 | 278 | 57 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 2.02e-04 | 279 | 57 | 6 | PS50003 | |
| Domain | PH_domain | 2.06e-04 | 280 | 57 | 6 | IPR001849 | |
| Domain | PH_dom-like | 3.02e-04 | 426 | 57 | 7 | IPR011993 | |
| Domain | RhoGAP | 8.97e-04 | 62 | 57 | 3 | SM00324 | |
| Domain | RhoGAP | 9.40e-04 | 63 | 57 | 3 | PF00620 | |
| Domain | DH_1 | 9.40e-04 | 63 | 57 | 3 | PS00741 | |
| Domain | RHOGAP | 9.84e-04 | 64 | 57 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 9.84e-04 | 64 | 57 | 3 | IPR000198 | |
| Domain | - | 9.84e-04 | 64 | 57 | 3 | 1.10.555.10 | |
| Domain | Post-SET_dom | 1.07e-03 | 16 | 57 | 2 | IPR003616 | |
| Domain | PostSET | 1.07e-03 | 16 | 57 | 2 | SM00508 | |
| Domain | POST_SET | 1.07e-03 | 16 | 57 | 2 | PS50868 | |
| Domain | RhoGEF | 1.17e-03 | 68 | 57 | 3 | SM00325 | |
| Domain | - | 1.19e-03 | 391 | 57 | 6 | 2.30.29.30 | |
| Domain | RhoGEF | 1.28e-03 | 70 | 57 | 3 | PF00621 | |
| Domain | DH_2 | 1.28e-03 | 70 | 57 | 3 | PS50010 | |
| Domain | DH-domain | 1.33e-03 | 71 | 57 | 3 | IPR000219 | |
| Domain | - | 1.33e-03 | 71 | 57 | 3 | 1.20.900.10 | |
| Domain | Rho_GTPase_activation_prot | 2.46e-03 | 88 | 57 | 3 | IPR008936 | |
| Domain | Arm | 4.02e-03 | 31 | 57 | 2 | PF00514 | |
| Domain | SH3 | 4.26e-03 | 216 | 57 | 4 | SM00326 | |
| Domain | SH3 | 4.26e-03 | 216 | 57 | 4 | PS50002 | |
| Domain | SH3_domain | 4.54e-03 | 220 | 57 | 4 | IPR001452 | |
| Domain | - | 4.69e-03 | 222 | 57 | 4 | 1.25.10.10 | |
| Domain | PH | 5.23e-03 | 229 | 57 | 4 | PF00169 | |
| Domain | GDS_CDC24_CS | 6.31e-03 | 39 | 57 | 2 | IPR001331 | |
| Domain | ARM_REPEAT | 6.63e-03 | 40 | 57 | 2 | PS50176 | |
| Domain | ARM | 6.63e-03 | 40 | 57 | 2 | SM00185 | |
| Domain | SET | 6.95e-03 | 41 | 57 | 2 | PF00856 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 8.63e-03 | 138 | 57 | 3 | IPR001245 | |
| Domain | SET | 8.69e-03 | 46 | 57 | 2 | SM00317 | |
| Domain | Armadillo | 9.06e-03 | 47 | 57 | 2 | IPR000225 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | PLEKHG1 ARHGAP22 LIMK2 ARHGEF28 CENPC CLASP1 ARHGAP31 CLASP2 ARHGEF2 ARHGAP21 GOLGA3 | 9.33e-06 | 720 | 44 | 11 | M41838 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | PLEKHG1 ARHGAP22 ARHGEF28 CENPC CLASP1 ARHGAP31 CLASP2 ARHGEF2 ARHGAP21 GOLGA3 | 2.39e-05 | 649 | 44 | 10 | MM15690 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 7.65e-05 | 142 | 44 | 5 | MM15576 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 9.61e-05 | 149 | 44 | 5 | M41805 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 2.05e-04 | 94 | 44 | 4 | MM15598 | |
| Pathway | REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING | 2.63e-04 | 8 | 44 | 2 | M27351 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 3.83e-04 | 439 | 44 | 7 | MM15595 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 4.44e-04 | 450 | 44 | 7 | M27078 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY | 6.16e-04 | 12 | 44 | 2 | M47929 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION | 9.74e-04 | 15 | 44 | 2 | M47854 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.29e-03 | 69 | 44 | 3 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.34e-03 | 70 | 44 | 3 | M41806 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.36e-03 | 155 | 44 | 4 | M41808 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 PLEKHG1 LIMK2 HIVEP1 ARHGEF28 CLASP1 KIF26B IQSEC1 APC KDM3B MAP3K9 MAP3K10 TBC1D22B CLASP2 ARHGEF2 SIPA1L2 OBI1 ARHGAP21 | 6.82e-15 | 861 | 62 | 18 | 36931259 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | UIMC1 SETD2 RAD18 HIVEP1 SETD1B CLASP1 DYNC2H1 APC ZNF318 SIPA1L2 OBI1 SLX4 PAPOLG | 3.15e-11 | 588 | 62 | 13 | 38580884 |
| Pubmed | Role of CLASP2 in microtubule stabilization and the regulation of persistent motility. | 5.38e-08 | 5 | 62 | 3 | 17113391 | |
| Pubmed | 9.51e-08 | 209 | 62 | 7 | 36779422 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UIMC1 SETD2 RAD18 HIVEP1 CLASP1 PKP3 IQSEC1 KDM3B ZNF318 ARHGEF2 PAPOLG | 1.12e-07 | 774 | 62 | 11 | 15302935 |
| Pubmed | ANK2 CLASP1 TRPC4 HECTD4 IQSEC1 APC CLASP2 ZNF318 ARHGEF2 ARHGAP21 GOLGA3 BEGAIN | 1.15e-07 | 963 | 62 | 12 | 28671696 | |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 5.78e-07 | 37 | 62 | 4 | 27565344 | |
| Pubmed | 6.42e-07 | 10 | 62 | 3 | 23001180 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.15e-06 | 440 | 62 | 8 | 34244565 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SETD2 RAD18 CLASP1 PKP3 IQSEC1 KDM3B CLASP2 OBI1 ARHGAP21 BEGAIN TJP3 | 2.01e-06 | 1038 | 62 | 11 | 26673895 |
| Pubmed | 2.40e-06 | 486 | 62 | 8 | 20936779 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 16914514 | ||
| Pubmed | Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis. | 3.13e-06 | 2 | 62 | 2 | 28825595 | |
| Pubmed | Human CLASP1 is an outer kinetochore component that regulates spindle microtubule dynamics. | 3.13e-06 | 2 | 62 | 2 | 12837247 | |
| Pubmed | The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. | 3.13e-06 | 2 | 62 | 2 | 11416147 | |
| Pubmed | Mammalian CLASPs are required for mitotic spindle organization and kinetochore alignment. | 3.13e-06 | 2 | 62 | 2 | 16866869 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 8477742 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 19701196 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 8536694 | ||
| Pubmed | Mast, a conserved microtubule-associated protein required for bipolar mitotic spindle organization. | 3.13e-06 | 2 | 62 | 2 | 10899121 | |
| Pubmed | 8.07e-06 | 407 | 62 | 7 | 12693553 | ||
| Pubmed | CLASP2 Links Reelin to the Cytoskeleton during Neocortical Development. | 9.37e-06 | 3 | 62 | 2 | 28285824 | |
| Pubmed | Mice lacking both mixed-lineage kinase genes Mlk1 and Mlk2 retain a wild type phenotype. | 9.37e-06 | 3 | 62 | 2 | 18414056 | |
| Pubmed | Asymmetric CLASP-dependent nucleation of noncentrosomal microtubules at the trans-Golgi network. | 9.37e-06 | 3 | 62 | 2 | 17543864 | |
| Pubmed | CLASPs attach microtubule plus ends to the cell cortex through a complex with LL5beta. | 9.37e-06 | 3 | 62 | 2 | 16824950 | |
| Pubmed | Plakophilin3 loss leads to increased adenoma formation and rectal prolapse in APCmin mice. | 9.37e-06 | 3 | 62 | 2 | 34823217 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 15928712 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 25756347 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 8195146 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 22307330 | ||
| Pubmed | 1.15e-05 | 430 | 62 | 7 | 32581705 | ||
| Pubmed | 1.46e-05 | 446 | 62 | 7 | 24255178 | ||
| Pubmed | NSMF ANK2 HECTD4 APC MAP3K10 REV3L ANKRD6 ARHGAP21 SLX4 RECK GOLGA3 | 1.51e-05 | 1285 | 62 | 11 | 35914814 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 33587225 | ||
| Pubmed | RAD18 transmits DNA damage signalling to elicit homologous recombination repair. | 1.87e-05 | 4 | 62 | 2 | 19396164 | |
| Pubmed | The membrane-anchored MMP-regulator RECK is a target of myogenic regulatory factors. | 1.87e-05 | 4 | 62 | 2 | 16007210 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 35445296 | ||
| Pubmed | RAD18 FRMPD1 APC MAP3K9 PHTF2 CLASP2 ZNF318 ANKRD6 ARHGAP21 SLX4 | 2.05e-05 | 1084 | 62 | 10 | 11544199 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLEKHG1 SETD1B HECTD4 KDM3B CLASP2 REV3L ARHGEF2 SIPA1L2 ARHGAP21 TJP3 | 2.41e-05 | 1105 | 62 | 10 | 35748872 |
| Pubmed | CLASP1 and CLASP2 bind to EB1 and regulate microtubule plus-end dynamics at the cell cortex. | 3.12e-05 | 5 | 62 | 2 | 15631994 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 27378169 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 11290329 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 24859005 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 23940118 | ||
| Pubmed | The human immunoglobulin kappa locus. Characterization of the duplicated O regions. | 3.12e-05 | 5 | 62 | 2 | 1907917 | |
| Pubmed | 3.39e-05 | 35 | 62 | 3 | 33864728 | ||
| Pubmed | 3.41e-05 | 102 | 62 | 4 | 9734811 | ||
| Pubmed | 3.63e-05 | 347 | 62 | 6 | 17114649 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 3.99e-05 | 353 | 62 | 6 | 27545878 | |
| Pubmed | An EB1-binding motif acts as a microtubule tip localization signal. | 4.67e-05 | 6 | 62 | 2 | 19632184 | |
| Pubmed | 4.88e-05 | 222 | 62 | 5 | 37071664 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 20937854 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 22742833 | ||
| Pubmed | 6.98e-05 | 777 | 62 | 8 | 35844135 | ||
| Pubmed | 8.28e-05 | 128 | 62 | 4 | 30995482 | ||
| Pubmed | The leukotriene receptors as therapeutic targets of inflammatory diseases. | 8.69e-05 | 8 | 62 | 2 | 31135881 | |
| Pubmed | 1.01e-04 | 418 | 62 | 6 | 34709266 | ||
| Pubmed | 1.08e-04 | 263 | 62 | 5 | 34702444 | ||
| Pubmed | Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex. | 1.12e-04 | 9 | 62 | 2 | 14504284 | |
| Pubmed | Integrated β-catenin, BMP, PTEN, and Notch signalling patterns the nephron. | 1.12e-04 | 9 | 62 | 2 | 25647637 | |
| Pubmed | ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. | 1.39e-04 | 10 | 62 | 2 | 18854161 | |
| Pubmed | 1.47e-04 | 57 | 62 | 3 | 29089450 | ||
| Pubmed | 1.47e-04 | 57 | 62 | 3 | 18022353 | ||
| Pubmed | Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence. | 1.70e-04 | 11 | 62 | 2 | 22488850 | |
| Pubmed | EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions. | 1.98e-04 | 63 | 62 | 3 | 29162697 | |
| Pubmed | 2.17e-04 | 481 | 62 | 6 | 28190767 | ||
| Pubmed | 2.75e-04 | 503 | 62 | 6 | 16964243 | ||
| Pubmed | Neurocalcin Delta Knockout Impairs Adult Neurogenesis Whereas Half Reduction Is Not Pathological. | 2.81e-04 | 14 | 62 | 2 | 30853885 | |
| Pubmed | 3.23e-04 | 733 | 62 | 7 | 34672954 | ||
| Pubmed | MAP3Ks as central regulators of cell fate during development. | 3.23e-04 | 15 | 62 | 2 | 18855897 | |
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 12056414 | ||
| Pubmed | 3.54e-04 | 187 | 62 | 4 | 26460568 | ||
| Pubmed | 3.69e-04 | 16 | 62 | 2 | 11256068 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 3.76e-04 | 190 | 62 | 4 | 15161933 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 4.02e-04 | 1005 | 62 | 8 | 19615732 | |
| Pubmed | 4.31e-04 | 197 | 62 | 4 | 36604605 | ||
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 4.67e-04 | 361 | 62 | 5 | 30344098 | |
| Pubmed | Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease. | 4.70e-04 | 18 | 62 | 2 | 24058526 | |
| Pubmed | 5.48e-04 | 1327 | 62 | 9 | 32694731 | ||
| Pubmed | 5.48e-04 | 210 | 62 | 4 | 16565220 | ||
| Pubmed | 7.06e-04 | 22 | 62 | 2 | 22902628 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 7.47e-04 | 608 | 62 | 6 | 36089195 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 7.82e-04 | 231 | 62 | 4 | 16452087 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 7.94e-04 | 101 | 62 | 3 | 24613305 | |
| Pubmed | 7.98e-04 | 1116 | 62 | 8 | 31753913 | ||
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 8.17e-04 | 102 | 62 | 3 | 15778465 | |
| Pubmed | 8.17e-04 | 102 | 62 | 3 | 10231032 | ||
| Pubmed | 9.32e-04 | 421 | 62 | 5 | 36976175 | ||
| Pubmed | ANK2 CLASP1 IQSEC1 APC CLASP2 ARHGEF2 SIPA1L2 ARHGAP21 GOLGA3 | 9.37e-04 | 1431 | 62 | 9 | 37142655 | |
| Pubmed | 9.58e-04 | 638 | 62 | 6 | 31182584 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 9.96e-04 | 1155 | 62 | 8 | 20360068 | |
| Pubmed | 1.05e-03 | 650 | 62 | 6 | 38777146 | ||
| Pubmed | Novel genes differentially expressed in cortical regions during late neurogenesis. | 1.15e-03 | 28 | 62 | 2 | 17614941 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.18e-03 | 444 | 62 | 5 | 34795231 | |
| Pubmed | 1.20e-03 | 916 | 62 | 7 | 32203420 | ||
| Pubmed | 1.23e-03 | 29 | 62 | 2 | 24105743 | ||
| Pubmed | 1.24e-03 | 118 | 62 | 3 | 21078624 | ||
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 1.28e-03 | 119 | 62 | 3 | 35776542 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.34e-03 | 934 | 62 | 7 | 33916271 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.40e-03 | 123 | 62 | 3 | 26912792 | |
| Interaction | YWHAH interactions | USP53 PLEKHG1 HIVEP1 ARHGEF28 CLASP1 KIF26B HECTD4 APC KDM3B MAP3K9 MAP3K10 TBC1D22B CLASP2 NKTR SAMSN1 ARHGEF2 SIPA1L2 ARHGAP21 | 3.11e-09 | 1102 | 62 | 18 | int:YWHAH |
| Interaction | YWHAG interactions | USP53 PLEKHG1 HIVEP1 ARHGEF28 CLASP1 KIF26B HECTD4 IQSEC1 APC KDM3B MAP3K9 MAP3K10 TBC1D22B CLASP2 NKTR SAMSN1 ARHGEF2 SIPA1L2 ARHGAP21 | 3.22e-09 | 1248 | 62 | 19 | int:YWHAG |
| Interaction | SFN interactions | USP53 ARHGEF28 CLASP1 KIF26B PKP3 APC MAP3K10 CLASP2 SAMSN1 ARHGEF2 SIPA1L2 OBI1 ARHGAP21 | 1.45e-07 | 692 | 62 | 13 | int:SFN |
| Interaction | YWHAB interactions | HIVEP1 ARHGEF28 CLASP1 KIF26B HECTD4 APC MAP3K9 MAP3K10 TBC1D22B CLASP2 SAMSN1 ARHGEF2 SIPA1L2 ARHGAP21 | 1.84e-06 | 1014 | 62 | 14 | int:YWHAB |
| Interaction | YWHAE interactions | RAD18 HIVEP1 ARHGEF28 CLASP1 KIF26B APC MAP3K9 MAP3K10 TBC1D22B CLASP2 SAMSN1 ARHGEF2 SIPA1L2 ARHGAP21 GOLGA3 | 4.43e-06 | 1256 | 62 | 15 | int:YWHAE |
| Interaction | YWHAZ interactions | HIVEP1 ARHGEF28 CLASP1 KIF26B HECTD4 APC MAP3K9 MAP3K10 TBC1D22B CLASP2 SAMSN1 ARHGEF2 SIPA1L2 ARHGAP21 GOLGA3 | 8.01e-06 | 1319 | 62 | 15 | int:YWHAZ |
| Interaction | NUP43 interactions | 1.92e-05 | 625 | 62 | 10 | int:NUP43 | |
| Interaction | SYNGAP1 interactions | 4.27e-05 | 307 | 62 | 7 | int:SYNGAP1 | |
| Interaction | MAPRE3 interactions | 7.46e-05 | 230 | 62 | 6 | int:MAPRE3 | |
| Interaction | TRIM36 interactions | 8.10e-05 | 144 | 62 | 5 | int:TRIM36 | |
| Interaction | ANKRD28 interactions | 8.40e-05 | 235 | 62 | 6 | int:ANKRD28 | |
| Interaction | GSK3A interactions | 8.45e-05 | 464 | 62 | 8 | int:GSK3A | |
| Interaction | DYNLT1 interactions | 9.65e-05 | 241 | 62 | 6 | int:DYNLT1 | |
| Interaction | NIN interactions | 1.14e-04 | 359 | 62 | 7 | int:NIN | |
| Interaction | SIRT6 interactions | 1.21e-04 | 628 | 62 | 9 | int:SIRT6 | |
| Interaction | MAD2L1 interactions | 1.23e-04 | 252 | 62 | 6 | int:MAD2L1 | |
| Interaction | YWHAQ interactions | ARHGEF28 CLASP1 KIF26B HECTD4 APC MAP3K9 MAP3K10 CLASP2 SAMSN1 ARHGEF2 SIPA1L2 ARHGAP21 | 1.31e-04 | 1118 | 62 | 12 | int:YWHAQ |
| Interaction | SRGAP1 interactions | 1.85e-04 | 92 | 62 | 4 | int:SRGAP1 | |
| Interaction | C6orf141 interactions | 1.85e-04 | 92 | 62 | 4 | int:C6orf141 | |
| Interaction | SPATA6L interactions | 1.94e-04 | 7 | 62 | 2 | int:SPATA6L | |
| Interaction | TERF2IP interactions | 2.77e-04 | 552 | 62 | 8 | int:TERF2IP | |
| Cytoband | 9p24.2 | 9.79e-05 | 11 | 62 | 2 | 9p24.2 | |
| GeneFamily | PDZ domain containing | 2.60e-05 | 152 | 42 | 5 | 1220 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.12e-04 | 50 | 42 | 3 | 721 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.31e-03 | 206 | 42 | 4 | 682 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.41e-03 | 24 | 42 | 2 | 654 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.82e-03 | 34 | 42 | 2 | 487 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.48e-03 | 43 | 42 | 2 | 409 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.03e-02 | 66 | 42 | 2 | 722 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | 1.59e-02 | 83 | 42 | 2 | 351 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-07 | 191 | 62 | 6 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 2.51e-06 | 155 | 62 | 5 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.80e-06 | 184 | 62 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.50e-06 | 194 | 62 | 5 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.78e-05 | 135 | 62 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | Ionocyte-iono-3|World / Class top | 8.44e-05 | 166 | 62 | 4 | 9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4 | |
| ToppCell | normal_Lung-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 9.46e-05 | 171 | 62 | 4 | f49dfe11ae66d82125b577c48345a13683d7bb7b | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.90e-05 | 173 | 62 | 4 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 176 | 62 | 4 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-04 | 178 | 62 | 4 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.10e-04 | 178 | 62 | 4 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 179 | 62 | 4 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 179 | 62 | 4 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | 15-Airway-Epithelial-Submucosal_gland|Airway / Age, Tissue, Lineage and Cell class | 1.15e-04 | 180 | 62 | 4 | 283bb0d58811947bfda4e286b9ec87d869c8e29e | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 183 | 62 | 4 | ad7421623e4c0c5ba02eec56e9bdae43ebb88d90 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-maDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-04 | 183 | 62 | 4 | e01dacb08a9c36cf09c0b6764ce032a7232d4cdc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-04 | 183 | 62 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 187 | 62 | 4 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 187 | 62 | 4 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 189 | 62 | 4 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-04 | 189 | 62 | 4 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 190 | 62 | 4 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 190 | 62 | 4 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 190 | 62 | 4 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 190 | 62 | 4 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 190 | 62 | 4 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 190 | 62 | 4 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 190 | 62 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-04 | 191 | 62 | 4 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILC2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 192 | 62 | 4 | 017f613b1b9c0bd0842e5c1e71d3ac60dd89eadd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 192 | 62 | 4 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.51e-04 | 193 | 62 | 4 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.51e-04 | 193 | 62 | 4 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.57e-04 | 195 | 62 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 196 | 62 | 4 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 197 | 62 | 4 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 197 | 62 | 4 | c1b2a3fbd5f4aeb3555d8c372efc86f1052e7c65 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.66e-04 | 198 | 62 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.66e-04 | 198 | 62 | 4 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.69e-04 | 199 | 62 | 4 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.73e-04 | 200 | 62 | 4 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.73e-04 | 200 | 62 | 4 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.73e-04 | 200 | 62 | 4 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 1.73e-04 | 200 | 62 | 4 | 3813fa1ee1462ba83fd8b6253070f46f0b063084 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.73e-04 | 200 | 62 | 4 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 9.35e-06 | 192 | 58 | 6 | 993_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; HL60; HT_HG-U133A | 1.05e-05 | 196 | 58 | 6 | 2331_UP | |
| Drug | Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.08e-05 | 197 | 58 | 6 | 2110_UP | |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.11e-05 | 198 | 58 | 6 | 7016_DN | |
| Drug | Bufexamac [2438-72-4]; Down 200; 18uM; MCF7; HT_HG-U133A | 1.11e-05 | 198 | 58 | 6 | 5515_DN | |
| Drug | sulindac sulfone; Down 200; 50uM; MCF7; HG-U133A | 1.15e-05 | 199 | 58 | 6 | 309_DN | |
| Drug | Ivermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 1.20e-04 | 189 | 58 | 5 | 7206_UP | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.29e-04 | 192 | 58 | 5 | 1792_UP | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.36e-04 | 194 | 58 | 5 | 2238_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.39e-04 | 195 | 58 | 5 | 6927_DN | |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.39e-04 | 195 | 58 | 5 | 4172_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 2101_UP | |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 5326_DN | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 4236_DN | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; HL60; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 3070_DN | |
| Drug | Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 4604_DN | |
| Drug | Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 6747_DN | |
| Drug | Meropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 7180_UP | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 6400_UP | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 3351_UP | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 1514_UP | |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 7283_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 2124_UP | |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 4694_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 1.49e-04 | 198 | 58 | 5 | 1002_UP | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 7032_DN | |
| Drug | Trazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 7452_DN | |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 4228_DN | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; HL60; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 3017_DN | |
| Drug | Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 2220_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; PC3; HT_HG-U133A | 1.56e-04 | 200 | 58 | 5 | 4006_UP | |
| Disease | Short Stature, CTCAE | 1.75e-04 | 10 | 59 | 2 | C2919142 | |
| Disease | Short stature | 1.75e-04 | 10 | 59 | 2 | C0349588 | |
| Disease | alcohol and nicotine codependence | 3.02e-04 | 13 | 59 | 2 | EFO_0004776 | |
| Disease | receptive language perception, parental genotype effect measurement | 3.52e-04 | 14 | 59 | 2 | EFO_0005686, EFO_0005939 | |
| Disease | gamma-glutamylphenylalanine measurement | 4.06e-04 | 15 | 59 | 2 | EFO_0021142 | |
| Disease | Abnormal behavior | 4.63e-04 | 16 | 59 | 2 | C0233514 | |
| Disease | Alpha ketoglutarate measurement | 4.63e-04 | 16 | 59 | 2 | EFO_0010457 | |
| Disease | response to radiation | 7.38e-04 | 88 | 59 | 3 | GO_0009314 | |
| Disease | skin hydration measurement | 8.05e-04 | 21 | 59 | 2 | EFO_0009586 | |
| Disease | renal system measurement, blood urea nitrogen measurement | 8.85e-04 | 22 | 59 | 2 | EFO_0004741, EFO_0004742 | |
| Disease | Dwarfism | 1.14e-03 | 25 | 59 | 2 | C0013336 | |
| Disease | gamma-glutamyltyrosine measurement | 1.34e-03 | 27 | 59 | 2 | EFO_0021144 | |
| Disease | C-X-C motif chemokine 10 measurement | 1.37e-03 | 109 | 59 | 3 | EFO_0008056 | |
| Disease | lumbar disc degeneration | 1.44e-03 | 28 | 59 | 2 | EFO_0004994 | |
| Disease | diastolic blood pressure, unipolar depression | 1.65e-03 | 30 | 59 | 2 | EFO_0003761, EFO_0006336 | |
| Disease | systolic blood pressure, alcohol drinking | 2.17e-03 | 128 | 59 | 3 | EFO_0004329, EFO_0006335 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLTCSDSQSRRVSSS | 211 | Q8TF63 | |
| SSRLSDASARDLAFC | 196 | Q9BUH8 | |
| SIELCRADSDSSQRD | 711 | Q92974 | |
| ASSLSRDDSSVFRCR | 336 | O00155 | |
| ADSVRSSNLSLCCSD | 26 | A6QL63 | |
| QELSSSDCTGSRLRN | 576 | Q9Y2G4 | |
| SDQDSCRLSIDSQSS | 201 | Q06710 | |
| SDSCNSSSSDIIRDL | 436 | Q9NS91 | |
| STRLCLSEHSSEDDR | 611 | O95980 | |
| LACDSRRVSFSQSSS | 206 | A0A1B0GVH7 | |
| NSCRSRSHSDELLQS | 781 | Q8N1W1 | |
| CTRDESSVQSSRSER | 1571 | Q01484 | |
| ISCRSSQSLLDSDDG | 41 | P01614 | |
| SVSDCNSTRSLLRSD | 751 | Q02779 | |
| SRDISRSESLRCSSS | 306 | P53671 | |
| DTINCSSESSSRDSL | 481 | Q6DN90 | |
| RICSTLARDTSESSS | 456 | Q2KJY2 | |
| SSRRGSQSDEDSCSL | 456 | Q9UPZ3 | |
| NSSCRSLSERDRSCD | 1091 | Q7Z5P9 | |
| ASIDSSASSSLRCLS | 206 | P23409 | |
| SASSSLRCLSSIVDS | 211 | P23409 | |
| SSSRLCDTSSARQES | 316 | Q5W0B1 | |
| ERSLACRQDSDSSTN | 801 | Q7LBC6 | |
| RDSSDLQSSHCTLDE | 306 | Q6X4W1 | |
| DRLCSLSNQTESSSS | 1296 | Q9Y4D8 | |
| RRDSICSSVSLESSA | 386 | Q08378 | |
| NRTNRSACLDLTSSD | 176 | Q96P68 | |
| SKRLSLDSSCLDSSR | 521 | Q9BWT3 | |
| LSDSRSGLCIEASSR | 546 | Q8NCM8 | |
| LDCSRSTRSSKNEDN | 631 | Q03188 | |
| ALEEDDLDTCSSSRS | 611 | Q5SYB0 | |
| ISCRSSQSLLDSDDG | 41 | A0A087WW87 | |
| CNSRLKDSSEDSSSS | 101 | Q8NCQ7 | |
| SECNSTRSLLRSDSD | 841 | P80192 | |
| CSSSRQDSESARPES | 386 | Q8N3S3 | |
| ERIVLRSDSSSCLDS | 276 | Q8N4H0 | |
| SSDAQLSRNSSDTCL | 131 | Q9NU19 | |
| KSSCDRERSSRSSSL | 476 | P30414 | |
| RSDSGSDLLRCTERT | 706 | Q5VVP1 | |
| SCSDGTSNRDSFRLD | 141 | Q9NSI8 | |
| LATSTSRSRQLSLCD | 126 | Q8TDN2 | |
| TLSDESICSNRRGSS | 1486 | Q9P2F8 | |
| QRRLLSSFTGSCDSD | 1801 | Q9UPS6 | |
| LSSCTACRASDSSAR | 526 | Q7Z5H3 | |
| SRDCSSQTQISSLRS | 1266 | Q8IY92 | |
| RCTSVSSLDSFESRS | 1386 | P25054 | |
| AACLSRQASSDSDSI | 2121 | P25054 | |
| GCSRDTSRESSRDTS | 751 | Q7Z460 | |
| QGCSREASRESSRDT | 526 | O75122 | |
| SRDRGNSCDSSSKSR | 566 | Q70EK8 | |
| SRSAVDLSCSRRLSS | 121 | Q9Y446 | |
| SLCRNTHRSSTEDDD | 486 | O60673 | |
| ESSRDCALSSTLEDT | 356 | Q96GC6 | |
| CLSSRSNSALTLTDT | 146 | Q9P273 | |
| SSSSCANLETERNSD | 971 | Q2M1Z3 | |
| RDLRTSSYSKSDRDC | 481 | Q9BYW2 | |
| ADSSADLSCDSRVNS | 791 | O95049 | |
| FSSSDLNSTRLCEDS | 566 | Q9ULL1 | |
| LNSTRLCEDSTSSRP | 571 | Q9ULL1 | |
| RLTSQDSSECFSSLS | 946 | Q9BXT5 | |
| CTEGSLTSSLDSRRQ | 1676 | Q5T5U3 | |
| LTDDSVFTRSSQCSR | 186 | Q5VUA4 | |
| ESLNSCRPSDASATR | 116 | Q96RL1 | |
| EQCDSSSLSSKTRTD | 161 | P15822 | |
| CVSSSDVDSLRHSRS | 181 | Q9UBN4 | |
| CARRSSQDSICSSSQ | 716 | B1ANS9 |